RxDoctor Payments Data

Tasos Aslanidis, DO

Otolaryngology/Facial Plastic Surgery · Philadelphia, PANPI 1568438703

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 76 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 14 manufacturers, the largest accounting for just 16.8% — the pattern of someone who eats at a lot of different presentations. That places this record below the midpoint for otolaryngology/facial plastic surgery clinicians in PA, where the typical reported total is $3,163.

$1,967in general payments, 2019–2025

Across 76 payments — averaging $25.88 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Sanofi$331
  • Inspire Medical Systems, Inc.$302
  • Regeneron Healthcare Solutions, Inc.$265
  • Optinose US, Inc.$219
  • GSK$183
  • Integra Lifesciences Corporation$173
  • plus $493 from 8 others

What the payments were for

  • Food & beverage$1,967100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,967 in reported general payments places this provider in the 45th percentile of 21 otolaryngology/facial plastic surgery providers in Pennsylvania.

See all otolaryngology/facial plastic surgery providers in Pennsylvania

Medicare billing

Part B allowed, 2024
$82,810
Medicare patients
251
Services billed
583

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Fluticasone Propionate74$1,278
Ipratropium Bromide54$957
Cefdinir33$754
Ciprofloxacin Hcl46$709
Fluocinolone Acetonide Oil22$661
Neomycin-Polymyxin-HcNeomycin/Polymyxin B/Hydrocort13$581
Azelastine Hcl30$546
Ofloxacin13$545
Montelukast Sodium30$475
Omeprazole20$473
Levocetirizine Dihydrochloride22$239
Cephalexin28$150
Mupirocin21$105
Methylprednisolone22$103
Doxycycline Hyclate14$90

Paid to pharmacies, not to this prescriber.

Other otolaryngology/facial plastic surgery in Philadelphia

See the full list for Pennsylvania

Where these figures come from

Is this you, or does something look wrong? →